Skip to Main Content

Author Details

Jonathan S Serody
The University of North Carolina School of Medicine
1991
157
57
PMIDPaper TitleJournal TitlePublished Year
36878433Enforced gut homing of murine regulatory T cells reduces early graft-versus-host disease severity.Am J Transplant2023
37669929A tissue-intrinsic IL-33/EGF circuit promotes epithelial regeneration after intestinal injury.Nat Commun2023
37527906Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+ lymphomas.J Immunother Cancer2023
37204246Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors.J Immunol2023
36882226Evaluation of tumor antigen-specific antibody responses in patients with metastatic triple negative breast cancer treated with cyclophosphamide and pembrolizumab.J Immunother Cancer2023
34666347Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma.Blood Adv2022
35437570The Landscape of Immune Microenvironments in Racially Diverse Breast Cancer Patients.Cancer Epidemiol Biomarkers Prev2022
35686131Alphavirus Replicon Particle Vaccine Breaks B Cell Tolerance and Rapidly Induces IgG to Murine Hematolymphoid Tumor Associated Antigens.Front Immunol2022
35226736BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes.Blood2022
35044794B Cell Function in the Tumor Microenvironment.Annu Rev Immunol2022
32976550Repurposing a novel anti-cancer RXR agonist to attenuate murine acute GVHD and maintain graft-versus-leukemia responses.Blood2021
33624095Utility of a safety switch to abrogate CD19.CAR T-cell-associated neurotoxicity.Blood2021
33623115Protein-based immune profiles of basal-like vs. luminal breast cancers.Lab Invest2021
33707624Targeted therapy of human leukemia xenografts in immunodeficient zebrafish.Sci Rep2021
33661190Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922).Melanoma Res2021
33580223Author Correction: Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy.Nat Nanotechnol2021
34474164Safety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia.Transplant Cell Ther2021
34607937Anti-PD-1 Checkpoint Therapy Can Promote the Function and Survival of Regulatory T Cells.J Immunol2021
34778801Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.Blood Cancer Discov2021
34619767Third-party type 2 innate lymphoid cells prevent and treat GI tract GvHD.Blood Adv2021
33382402STING agonist promotes CAR T cell trafficking and persistence in breast cancer.J Exp Med2021
31502156Using RNA Sequencing to Characterize the Tumor Microenvironment.Methods Mol Biol2020
31697815Inhibition of inositol kinase B controls acute and chronic graft-versus-host disease.Blood2020
32013193Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients.Int J Mol Sci2020
31880771Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD.Blood2020
33259598Long-term remission in multiply relapsed enteropathy-associated T-cell lymphoma following CD30 CAR T-cell therapy.Blood Adv2020
32701411Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma.J Clin Oncol2020
32134744Minimal PD-1 expression in mouse and human NK cells under diverse conditions.J Clin Invest2020
30279226Small-molecule BCL6 inhibitor effectively treats mice with nonsclerodermatous chronic graft-versus-host disease.Blood2019
31730857B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer.Cell2019
30244102Evaluation of a Test Dose Strategy for Pharmacokinetically-Guided Busulfan Dosing for Hematopoietic Stem Cell Transplantation.Biol Blood Marrow Transplant2019
31533918Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD.Blood2019
31578305Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality.JCI Insight2019
31433971The Immune Landscape of Cancer.Immunity2019
31515258Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes.Cancer Immunol Res2019
31278396Alternative tumour-specific antigens.Nat Rev Cancer2019
30885956Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease Lethality.J Immunol2019
30748099Targeting PI3Kδ function for amelioration of murine chronic graft-versus-host disease.Am J Transplant2019
29196464Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers.Cancer Discov2018
30135306Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma.JCI Insight2018
30106752The vimentin intermediate filament network restrains regulatory T cell suppression of graft-versus-host disease.J Clin Invest2018
30228128Impaired bone marrow B-cell development in mice with a bronchiolitis obliterans model of cGVHD.Blood Adv2018
30137025Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma.J Clin Invest2018
29691900A Dual Immunotherapy Nanoparticle Improves T-Cell Activation and Cancer Immunotherapy.Adv Mater2018
29769260Bim regulates the survival and suppressive capability of CD8<sup>+</sup> FOXP3<sup>+</sup> regulatory T cells during murine GVHD.Blood2018
29513764Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors.PLoS One2018
28941323A critical role for donor-derived IL-22 in cutaneous chronic GVHD.Am J Transplant2018
27354470A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases.Clin Cancer Res2017
28341226Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.J Thorac Oncol2017
28254742Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production.Blood2017
  • 1 - 50 of 157

Recommended Authors

Sawa Ito
University of Pittsburgh
Career Start Year 2013
Number of shared co-authors 7
Dipti Vijayan
QIMR Berghofer Medical Research Institute
Career Start Year 2011
Number of shared co-authors 3
Moutih Rafei
Universite de Montreal
Career Start Year 2007
Number of shared co-authors 0
Jordi Ochando
Icahn School of Medicine at Mount Sinai
Career Start Year 2004
Number of shared co-authors 0
Kristin Baird
National Cancer Institute, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 5
Robert S Welner
University of Alabama at Birmingham
Career Start Year 2002
Number of shared co-authors 1
Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Career Start Year 2002
Number of shared co-authors 0
Martin Prlic
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 1
Miriam Merad
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 2
Evan F Lind
Oregon Health & Science University
Career Start Year 1999
Number of shared co-authors 1
Sunil K Joshi
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 0
Masaki Terabe
National Cancer Institute
Career Start Year 1997
Number of shared co-authors 0
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 2
Cynthia Perez
Loyola University Chicago
Career Start Year 1995
Number of shared co-authors 0
Zhiya Yu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 3
Matthias Edinger
Regensburg University Hospital
Career Start Year 1994
Number of shared co-authors 5
Daniel H Fowler
National Cancer Institute, National Institutes of Health
Career Start Year 1993
Number of shared co-authors 7
Firouzeh Korangy
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1992
Number of shared co-authors 1
Hiroshi Kawamoto
Institute for Life and Medical Sciences, Kyoto University
Career Start Year 1991
Number of shared co-authors 3
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 6
Volker Eckstein
Heidelberg University
Career Start Year 1990
Number of shared co-authors 0
Drake Laface
Merck & Co. Inc.
Career Start Year 1987
Number of shared co-authors 2
Denis-Claude Roy
Universite de Montreal
Career Start Year 1985
Number of shared co-authors 2
Su M Metcalfe
University of Cambridge Clinical School, LIFNanoRx Ltd
Career Start Year 1984
Number of shared co-authors 0
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 18
Richard T Maziarz
Oregon Health & Science University
Career Start Year 1983
Number of shared co-authors 6
Anne M Dickinson
Translational and Clinical Research Institute, Newcastle University
Career Start Year 1981
Number of shared co-authors 4
John F DiPersio
Washington University School of Medicine
Career Start Year 1978
Number of shared co-authors 12
Shigeo Koyasu
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year 1966
Number of shared co-authors 3
David W Scott
University of British Columbia
Career Start Year 1965
Number of shared co-authors 1

Collaborators

Benjamin G Vincent
UNC School of Medicine, The University of North Carolina at Chapel Hill
Co-authored papers 34
William J Murphy
Co-authored papers 23
Ryan A Flynn
Boston Children's Hospital
Co-authored papers 13
Jerome Ritz
Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital
Co-authored papers 12
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Co-authored papers 10
Jeffrey A Frelinger
Co-authored papers 9
Charles M Perou
Co-authored papers 8
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 5
Lisa A Carey
Co-authored papers 4
Susan E Burkett
Co-authored papers 3
Peter T Sage
Transplant Research Center, Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 3
Dante S Bortone
Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill
Co-authored papers 3
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Lisle E Mose
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 2
Aguirre A de Cubas
Co-authored papers 2
Laura E Herring
Co-authored papers 2
Carey K Anders
Co-authored papers 2
Andrew D Clouston
University of Queensland
Co-authored papers 2
Wendy Kimryn Rathmell
Co-authored papers 2
James E Bradner
Co-authored papers 2
Melissa A Troester
Co-authored papers 2
David A Rizzieri
Duke University Medical Center
Co-authored papers 2
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Co-authored papers 2
Jun Qi
Dana-Farber Cancer Institute
Co-authored papers 2
Norman E Sharpless
National Cancer Institute
Co-authored papers 2
Nicholas P Restifo
National Cancer Institute, National Institutes of Health (NIH)
Co-authored papers 1
Thomas A Neubert
Neuroscience Institute, NYU Grossman School of Medicine
Co-authored papers 1
David L Gibbs
Institute for Systems Biology
Co-authored papers 1
Mark E Sherman
Mayo Clinic
Co-authored papers 1
Frances T Hakim
National Cancer Institute
Co-authored papers 1
Release 1.2